Page last updated: 2024-08-23

alkenes and Granulocytic Leukemia, Chronic

alkenes has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arbi, ME; Gargouri, A; Gupta, GK; Jaouen, G; Ketata, E; Mihoubi, W; Neifar, A; Pigeon, P; Top, S	1

Other Studies

1 other study(ies) available for alkenes and Granulocytic Leukemia, Chronic

Article	Year
Aryl Butenes Active against K562 Cells and Lacking Tyrosinase Inhibitory Activity as New Leads in the Treatment of Leukemia. Mini reviews in medicinal chemistry, 2018, Volume: 18, Issue:15 Topics: Alkenes; Apoptosis; Binding Sites; Catalytic Domain; Cell Proliferation; Enzyme Inhibitors; Humans; Hydrogen Bonding; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Conformation; Molecular Docking Simulation; Monophenol Monooxygenase; Tamoxifen	2018

Article

Year

Aryl Butenes Active against K562 Cells and Lacking Tyrosinase Inhibitory Activity as New Leads in the Treatment of Leukemia.

Mini reviews in medicinal chemistry, 2018, Volume: 18, Issue:15

Topics: Alkenes; Apoptosis; Binding Sites; Catalytic Domain; Cell Proliferation; Enzyme Inhibitors; Humans; Hydrogen Bonding; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Conformation; Molecular Docking Simulation; Monophenol Monooxygenase; Tamoxifen

2018